HiTech Pharmacal Co. Inc. (HITK) Vice Chairman, Business Dev't Reuben Seltzer sells 10,000 Shares

Vice Chairman, Business Dev't of HiTech Pharmacal Co. Inc. (HITK, Financial) Reuben Seltzer sells 10,000 shares of HITK on 10/16/2012 at an average price of $32.85 a share.

Hi-tech Pharmacal Co. has a market cap of $437.7 million; its shares were traded at around $33.31 with a P/E ratio of 11 and P/S ratio of 1.9.

CEO Recent Trades:

  • CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 50,000 shares of HITK stock on 10/16/2012 at the average price of 32.75. David S Seltzer owns at least 1,459,822 shares after this. The price of the stock has increased by 1.71% since.

CFO Recent Trades:

  • VP and CFO William J Peters sold 12,500 shares of HITK stock on 08/15/2012 at the average price of 35.5. The price of the stock has decreased by 6.17% since.
  • VP and CFO William J Peters sold 4,983 shares of HITK stock on 07/16/2012 at the average price of 32. The price of the stock has increased by 4.09% since.

Directors and Officers Recent Trades:

  • Director Hulst Jack Van sold 3,000 shares of HITK stock on 10/16/2012 at the average price of 32.75. The price of the stock has increased by 1.71% since.
  • Vice Chairman, Business Dev't Reuben Seltzer sold 21,250 shares of HITK stock on 10/12/2012 at the average price of 33.12. Reuben Seltzer owns at least 831,268 shares after this. The price of the stock has increased by 0.57% since.
  • President, HCP Division Gary M April sold 20,624 shares of HITK stock on 07/17/2012 at the average price of 30.91. The price of the stock has increased by 7.76% since.
  • Director Martin M Goldwyn sold 6,357 shares of HITK stock on 07/17/2012 at the average price of 31.4. The price of the stock has increased by 6.08% since.
  • Chief Scientific Officer, EVP Kamel Egbaria sold 11,342 shares of HITK stock on 07/17/2012 at the average price of 32.56. The price of the stock has increased by 2.3% since.


For the complete insider trading history of HITK, click here.